717 Innovative Technologies in Pharmaceutical Discovery, Manufacturing and Delivery


Description:
This session will include presentations that describe applications of innovative technologies in pharmaceutical discovery, manufacturing and delivery.

Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum
Co-Sponsor(s):
Pharmaceuticals (15B), Next-Gen Manufacturing (T6A)


Chair:
Christopher L. Burcham
Senior Engineering Research Advisor
Eli Lilly & Company
Indianapolis, IN
46285
Email: cburcham@lilly.com

Co-Chair:
Elcin Icten
Amgen

Email: eicten@amgen.com


Papers:
Oral Formulations: Perspectives from Additive Manufacturing
Andrew J. Radcliffe, Purdue University; Zoltan K. Nagy, Purdue University; Gintaras V. Reklaitis, Purdue University
Predicting the Free Energy of Solvation: A Hybrid QSPR Model for Organic Solute/Solvent Pairs
Tohid Borhani, Imperial College London; Salvador García-Muñoz, D; Carla Luciani, Eli Lilly and Company; Amparo Galindo, Imperial College London; Claire S. Adjiman, Imperial College London
In silico Prediction of Absolute Rates of Crystal Growth from Solution
Mark Joswiak, University of California-Santa Barbara; Baron Peters, University of California Santa Barbara; Michael F. Doherty, UC Santa Barbara
Mathematical Modeling and Simulation of Magnetophoresis. Application to Drug Delivery Using Magnetic-Field
Meenesh R. Singh, University of Illinois at Chicago; Andreas Linninger, University of Illinois at Chicago
Polyalkoxylated Alcohols As Excipients for Poorly Soluble Drugs
Jin Zhao, The Dow Chemical Co.; Tom Kalantar, Dow Chemical; Mladen Ladika, Dow Chemical Co; Keith Harris, Dow Chemical Co; Christopher Tucker, The Dow Chemical Company; Michael Tulchinsky, Dow Chemical Co; TC Kuo, Dow Chemical Co; Joe Kiefer, Dow Chemical Co; Xiaoyun Chen, Dow Chemical Co; Robert Krystosek, Dow Chemical Co
2D Printed Product Design of Patient Centric Dosage Forms for Adaptive Clinical Trials
Diogo G. Lopes, Research Center Pharmaceutical Engineering (RCPE) GmbH; Wen-Kai Hsiao, Research Center Pharmaceutical Engineering (RCPE) GmbH; Miriam Wimmer-Teubenbacher, Research Center Pharmaceutical Engineering (RCPE) GmbH; Thomas Wutscher, Research Center Pharmaceutical Engineering (RCPE) GmbH; Amrit Paudel, Research Center Pharmaceutical Engineering (RCPE) GmbH; Massimo Bresciani, Research Center Pharmaceutical Engineering (RCPE) GmbH; Patrizia Ghiotti, UCB S.A.; Frédéric Eeckman, UCB S.A.; Johannes G. Khinast, Graz University of Technology
Abstract Submissions Closed